Author

Carlos Carretero-Puche

Research Institute Hospital 12 de OctubreORCID 0000-0003-0474-8668Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Fátima Al‐ShahrouriD· 2 shared Gonzalo Goméz-LópeziD· 2 shared Santiago García‐MartíniD· 2 shared Coral Fustero TorreiD· 1 shared Daniel Glez‐PeñaiD· 1 shared Guillermo Martín‐Serrano· 1 shared Hugo López-FernándeziD· 1 shared Jordi Martorell‐MarugániD· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Fátima Al‐ShahrourORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsGenome MedicinePeer-reviewedDec 1, 2021

Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq

Coral Fustero Torre, María José Jiménez‐Santos, Santiago García‐Martín…·Fátima Al‐Shahrour

Beyondcell identifies drug-responsive subpopulations in single-cell RNA-seq data and proposes cancer-specific treatments by analyzing therapeutic clusters and differential drug sensitivity.

130 citationstop 2%

humanscRNA-seq

𝕏 PostBluesky

BioinformaticsBioinformaticsPeer-reviewedAug 16, 2020

DREIMT: a drug repositioning database and prioritization tool for immunomodulation.

Kevin Troulé, Hugo López-Fernández, Santiago García‐Martín…·Gonzalo Goméz-López

DREIMT prioritizes immunomodulatory drugs by analyzing gene expression signatures and drug profiles.

17 citations

statistical modeldrug response / drug discovery

𝕏 PostBluesky